Article
Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress and Boosting Economics Through Enhanced Insights
Published on Technology Networks Drug Discovery
Jul 03, 2023
Download

Published on Technology Networks by Chris Driver, Director of IRT Architecture at IQVIA, this article discusses the use of big data and Interactive Response Technology (IRT) in clinical trials, allowing for real-time interim analysis and more informed decisions about trial modifications. It highlights the role of regulatory authorities in defining parameters for the use of AI and ML in trials, and the potential of these to revolutionize trials, improve patient retention, and enhance the quality of life for trial participants.

Related solutions

Contact Us